ADEASY SYSTEM
ANDROGEN RECEPTOR
ANDROGEN RECEPTOR
AR-DEPENDENT MANNER
AS3
AS3
AS3 OVEREXPRESSION MIMIC
ANDROGEN-MEDIATED CELL CYCLE ARREST AS3 OVEREXPRESSION MIMIC
ATCC
ATP
ATP
ATP
REGENERATING SYSTEM ATP
ATP-DEPENDENT ACTIVATION
UBIQUITIN ATP-DEPENDENT ACTIVATION
AB-1
AB-2
AB-6
ABBREVIATION
AD-SKP2
AD-SKP2
AD-SKP2
AD-SKP2-ΔF
AD-SKP2-ΔF
AD-SKP2-ΔF
ADENOVIRAL DNA
ADENOVIRUS
ADOBE PHOTOSHOP
ALIQUOT
AMERSHAM HYBOND N
AMPLIFIED VIRUS
ANDROGEN CONTROL
LNCAP CELL PROLIFERATION ANDROGEN CONTROL
ANDROGEN-INDUCED G1 ARREST
ANTIBODY
B-SKP2
B. VOGELSTEIN
BJ-ADEASY CELL
BJ-ADEASY CELL
BIOCHEMICAL STUDY
C-TERMINAL LEUCINE-RICH REPEAT
C. SONNENSCHEIN
CYPROTERONE ACETATE
CYPROTERONE ACETATE
CYPROTERONE ACETATE
CDK2
CDK2
CDK2
CDK2
CDK2
CDK2 ACTIVATION
CDK2 ACTIVATION
CDK2 ACTIVATION
CDK2 ACTIVITY
CDK2 ACTIVITY
CDK2 COMPLEX
CDK2 COMPLEX
CDK2 COMPLEX
CDK2 INHIBITION
CDK2 INHIBITOR P27
CDK2 KINASE ACTIVITY
CDK2 KINASE ACTIVITY
CDK2 KINASE ACTIVITY
CDK
CDK
CHX
CKS1
COP9
COP9
CRL-10995
CSN5
CSN5
CSN5
CSN5
CSN5
CSN5
CSN5
CULLIN 1
CULLIN 1
CULLIN 1
CULLIN 1
CELL LYSATE
CELL LYSATE
CELL LYSATE
IMMUNOPRECIPITATION CELL LYSATE
COMPLEMENTARY DNA FRAGMENT
SKP2 COMPLEMENTARY DNA FRAGMENT
COVERSLIP
CULLIN/F-BOX PROTEIN COMPLEX UBC
CYCLIN
DHT-TREATED CELL
DEMARZO
E3 UBIQUITIN LIGASE
F-BOX
F-BOX
F-BOX
F-BOX
F-BOX
F-BOX DEPENDENCY
F-BOX-DEPENDENT P27 UBIQUITYLATION
FETAL BOVINE SERUM
G BEAD
G1 ARREST
G1 ARREST
G1 ARREST
GLYCERALDEHYDE 3 PHOSPHATE           DEHYDROGENASE
GAPDH PROBE
GENETEX MS-JAB11-PX1
H.S
HRT1
HRT1
HRT1
IP-LB
IP-LB
IP-LB
IMMOBILON P MEMBRANE
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOCOMPLEX
IMMUNOLOGICAL TECHNIQUE
CELL LYSATE IMMUNOLOGICAL TECHNIQUE
INFECTION
ASYNCHRONOUS LNCAP CELL INFECTION
JAB1
JAB1
JAB1
L-F
LNCAP CELL LYSATE
LNCAP CELL LYSATE
LNCAP CELL LYSATE
LNCAP CELL PROLIFERATION
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELL
LNCAP CELLS EXHIBIT
LNCAP M
RRNAS, LNCAP M
LYSATE
MCF7 CELL
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
MITOCHONDRIA           ISOLATION BUFFER
ARRESTED LNCAP CELL MITOCHONDRIA           ISOLATION BUFFER
CAUSED ARREST MITOCHONDRIA           ISOLATION BUFFER
INDUCED INHIBITION MITOCHONDRIA           ISOLATION BUFFER
MIB-ARRESTED LNCAP CELL
MIB-ARRESTED CELL
MIB-ARRESTED CELL
MIB-EXPOSED CELL
MIB-INDUCED G1 CELL CYCLE ARREST
MIB-INDUCED G1 CELL CYCLE ARREST
MIB-INDUCED RB1 DOWNREGULATION
MIB-INDUCED CELL CYCLE ARREST
MIB-INDUCED P27 UPREGULATION
MIB-INDUCED P27 UPREGULATION
MIB-TREATED LNCAP CELL
MIB-TREATED CELL
MIB-TREATED CELL
MS-1061
MS-870
MGCL
MIBOLERONE
MICROGRAPH
MILLIPORE
N-TERMINAL MYC EPITOPE TAG
NEOMARKER
NEOMARKER
NEOMARKER
AB-1 NEOMARKER
AB-2 NEOMARKER
AB-6 NEOMARKER
NIKON E600 EPIFLUORESCENCE MICROSCOPE
NORTHERN BLOTTING
NORTHERN BLOTTING ISOLATION
OVEREXPRESSION
OVEREXPRESSION
OVEREXPRESSION
PHOSPHATE           BUFFERED SALINE
PHOSPHATE           BUFFERED SALINE
PHOSPHATE           BUFFERED SALINE
PHOSPHATE           BUFFERED SALINE
PCR
PCR
PCR
PCR
PTEN
PERKIN ELMER LIFE SCIENCE
PHARMINGEN
POLYUBIQUITYLATION
WILDTYPE POLYUBIQUITYLATION
PROTEIN SYNTHESIS
QUICKCHANGE KIT
RB-012
RB1
RB1
RB1
RB1 PHOSPHORYLATION
RB1 SUPPRESSION
RBX1
RRNAS,
ROC1
RPMI
RE-ADMINISTRATION
ANDROGEN RE-ADMINISTRATION
RECENT STUDY
INVOLVING ANDROGEN ADMINISTRATION RECENT STUDY
RECOMBINANT ADENOVIRAL DNA
S PHASE
S PHASE
S PHASE
S PHASE
S PHASE ENTRY
S PHASE ENTRY
S PHASE ENTRY
S PHASE KINASE
ASSOCIATED PROTEIN S PHASE KINASE
SCF
SCF
SCF
SCF
SCF
SD
SD
SD
SD
SD
SD
SD
GEL ELECTROPHORESI SD
GEL ELECTROPHORESI SD
GEL ELECTROPHORESI SD
SAMPLE BUFFER SD
SAMPLE BUFFER SD
SKP
SKP-ΔF
SKP1
SKP1
SKP1
SKP1
SKP1
SKP1
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2
SKP2-INDUCED UPREGULATION
CYCLIN SKP2-INDUCED UPREGULATION
SKP2-MEDIATED P27 DEGRADATION
SKP2-MEDIATED P27 DOWNREGULATION
SKP2-ΔF
SKP2-ΔF MUTANT
SKP2-ΔF OVEREXPRESSING CELL
SSC
SSC
SSC
SANTA CRUZ SC-7164
SANTO CRUZ BIOTECHNOLOGY SC-163
SIGMA
SIMULTANEOUS ADMINISTRATION
MITOCHONDRIA           ISOLATION BUFFER SIMULTANEOUS ADMINISTRATION
STRATAGENE
TISSUE CULTURE LNCAP-FGC CELL
TRANSDUCTION LABORATORY
TRITON X100
TRITON X100
TRITON X100
TRITON X100
TUBULIN
TWEEN
UBC3
UBIQUITIN
CONJUGATING ENZYME MIB UBIQUITIN
UBIQUITYLATION SUBSTRATE
X-RAY FILM
ZYMED
ZYMED
ACCUMULATION
ACCUMULATION
ACCUMULATION
ACCUMULATION
ACCUMULATION
P27 ACCUMULATION
P27 PROTEIN ACCUMULATION
ADDITION
ADDITION
ADDITION
ADDITION
ADDITION
ADDITION
ADDITION
SD ADDITION
SAMPLE BUFFER SD ADDITION
ADENOVIRUS
ADENOVIRUS
ADVANCED CANCER
AFFINITY-PURIFIED RABBIT POLYCLONAL
AGGRESSIVE PROSTATE CANCERS DISPLAY
DECREASED P27 PROTEIN LEVEL AGGRESSIVE PROSTATE CANCERS DISPLAY
ALANINE
ANDROGEN
ANDROGEN
ANDROGEN
ANDROGEN
ANDROGEN
ANDROGEN ACTIVITY
ANDROGEN ADMINISTRATION
ANDROGEN CONTROL
ANDROGEN CONTROL
P27 EXPRESSION ANDROGEN CONTROL
ANDROGEN DIHYDROTESTOSTERONE
ANDROGEN LEVEL
ANDROGEN RECEPTOR
ANDROGEN RESPONSE MECHANISM
LNCAP CELL ANDROGEN RESPONSE MECHANISM
ANDROGEN-INDUCED G1 ARREST
ANDROGEN-INDUCED GROWTH ARREST
ANDROGEN-INDUCED P27 UPREGULATION
ANDROGEN-MEDIATED G1 ARREST
ANDROGEN-MEDIATED CELL CYCLE ARREST
ANDROGEN-MEDIATED CELL CYCLE CONTROL
ANDROGEN-MEDIATED CELL CYCLE CONTROL
ANDROGEN-MEDIATED GROWTH CONTROL
ANDROGEN-MEDIATED P27 ACCUMULATION
ANDROGEN-MEDIATED P27 CONTROL
ANDROGEN-SENSITIVE HUMAN PROSTATE CANCER CELL LINE LNCAP
ANDROGEN
ANDROGEN
ANDROGEN
ANEUPLOID DERIVATIVE
METASTATIC LESION ANEUPLOID DERIVATIVE
ADVANCED CANCER METASTATIC LESION ANEUPLOID DERIVATIVE
ANTI-SENSE AS3
ANTIANDROGEN CYPROTERONE ACETATE
ANTIANDROGEN CYPROTERONE ACETATE
ANTIBODY
ANTIBODY
ANTIBODY INCUBATION
APOPTOSI
APOPTOSIS-INDUCING ACTIVITY
ARRESTED LNCAP CELL
ASSAY
ASSOCIATED PROTEIN
ASYNCHRONOUS LNCAP CELL
AUTORADIOGRAPHY
AUTORADIOGRAPHY
BACULOVIRUS
BUFFER
CANCER CELL LINE
CANCER CELL
CASTRATION LEAD
CAUSED ARREST
CAUSED TRANSIENT UPREGULATION
CYCLIN CAUSED TRANSIENT UPREGULATION
CELL CYCLE
CELL CYCLE EXIT
CELL CYCLE-DEPENDENT VARIATION
CELL LINE LNCAP
CELL LINE UNDERGO
CELL LYSATE
CELL LYSATE
CELL LYSATE
CELLULAR RNA
CENTRIFUGATION
CENTRIFUGATION
CESIUM CHLORIDE GRADIENT CENTRIFUGATION
CHARACTERISTIC BIPHASIC RESPONSE
CIRCUMSTANTIAL EVIDENCE
CO-EXPRESSION
CYCLIN CO-EXPRESSION
COATED GLASS COVERSLIP
CONCENTRATION
CONCENTRATION
CONJECTURE
CONJUGATING ENZYME
CONJUGATING ENZYME MIB
CONSOLIDATION EFFECT
CONTINUOUS PRESENCE
CONTINUOUS PRESENCE
MITOCHONDRIA           ISOLATION BUFFER CONTINUOUS PRESENCE
ANDROGEN CONTINUOUS PRESENCE
CONTRIBUTION
CONTROL CELL
CONTROL CELL
CONTROL LEVEL
COORDINATION
COVERSLIP
CRITICAL CDK2 PHOSPHORYLATION SITE
CYCLIN
CYCLIN
CYCLIN
CYCLIN
CYCLIN
CYCLIN
CYCLIN
CYCLIN
CYCLIN
CYCLIN E
CYCLIN E
CYCLIN E
CYCLIN E
CYCLIN E
CYCLIN E
CYCLIN E COMPLEX
CYCLIN E COMPLEX
CYCLIN E IMMUNOCOMPLEX
CYCLIN E KINASE ACTIVITY
CYCLIN E LEVEL
CYCLIN E LEVEL
CYCLIN E-ASSOCIATED H1 KINASE ACTIVITY
CYCLIN-DEPENDENT KINASE
CYCLIN-DEPENDENT KINASE
CYCLINE
CYCLIN
CYCLOHEXIMIDE
CYTOTOXIC
DECREASED P27 PROTEIN LEVEL
DECREASED SURVIVAL
DECREASED UBIQUITYLATION
DECREASED UBIQUITYLATION NORTHERN BLOT ANALYSIS
DEMONSTRATED SKP2-INDEPENDENT PROTEOLYSI
P27 DEMONSTRATED SKP2-INDEPENDENT PROTEOLYSI
DETERMINANT
P27 LEVEL DETERMINANT
DIFFERENTIATED SECRETORY CELL
DIFFERENTIATION
DISPLAY DOWN-REGULATION
P27 DISPLAY DOWN-REGULATION
DOWNREGULATE P27 LEVEL
DOWNREGULATION
DOWNREGULATION
DOWNREGULATION
DOWNREGULATION
RB1 DOWNREGULATION
CYCLIN-DEPENDENT KINASE DOWNREGULATION
DRIVE S PHASE ENTRY
ECTOPIC DEGRADATION
ECTOPIC PROTEOLYSI
ELECTROPORATION
ENABLING ESCAPE
ENCODED PROTEIN
ENZYMATIC REACTION
ETHANOL
EXCLUSIVE
EXPRESSING EXOGENOUS AR
FINAL MANUSCRIPT
FIXED
FLOW CYTOMETRY
FLOW CYTOMETRY
FORGE P27 DOWN-REGULATION
FOUR-FOLD
FRACTION
GEL ELECTROPHORESI
GEL ELECTROPHORESI
GEL ELECTROPHORESI
GEL ELECTROPHORESI
GEL ELECTROPHORESI
GLANDULAR STRUCTURE
GROWTH
INHIBITING LEVEL GROWTH
GROWTH INHIBITION
H COURSE
H. CELL
HISTONE
HOMOZYGOUS INACTIVATION
HUMAN E1
HUMAN U87 CELL
HUMAN U87 CELL
HUMAN U87 CELL
HUMAN LAMIN B LEADER SEQUENCE
HYPOTONIC LYSI
HYPOTONIC LYSI
IDENTIFIED ANDROGEN-MEDIATED PATHWAY
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOBLOTTING
IMMUNOFLUORESCENCE
IMMUNOFLUORESCENCE
IMMUNOFLUORESCENCE
IMMUNOPRECIPITATION
IMMUNOPRECIPITATION
IMMUNOPRECIPITATION
IN VITRO ASSAY
IN VITRO STUDY
IN VITRO TRANSCRIPTION
IN VITRO TRANSCRIPTION
IN VITRO TRANSCRIPTION
INACTIVATION
INCREASED P27 PROTEIN STABILITY
INCREASED P27 UBIQUITYLATION ACTIVITY
INCREASED PROTEOLYSI
INCREASED RECOVERY
INCREASED RECOVERY
P27 INCREASED RECOVERY
CDK2 INHIBITOR P27 INCREASED RECOVERY
INDEPENDENT EXPERIMENT
INDUCED INHIBITION
INDUCTION
CYCLIN INDUCTION
INFECTION
INFECTION
INFECTION
INFECTION
INHIBITING LEVEL
INHIBITOR P27
INTEGRAL COMPONENT
ANDROGEN-MEDIATED GROWTH CONTROL INTEGRAL COMPONENT
LNCAP CELL ANDROGEN-MEDIATED GROWTH CONTROL INTEGRAL COMPONENT
INTERMEDIATE STEP
INTERPRETATION
INTERVENTION
INVASIVE CARCINOMA
INVERSE CORRELATION
INVOLVING ANDROGEN ADMINISTRATION
LACKING CSN SUBUNIT
LYMPHOCYTE
MM ATP
MM ATP
MM DTT
MM HEPE
PH MM HEPE
MM KCL
MM NACL
MM PMSF
MM PMSF
MM TRI
MM CREATINE PHOSPHATE
MAJOR DETERMINANT
P27 DEGRADATION MAJOR DETERMINANT
MEAN GLEASON SCORE
METASTATIC LESION
MG/ML UBIQUITIN
MIBOLERONE
MICROSCOPY SLIDE
MIN
MIN
MIN
MIN
MIN
MODEL SYSTEM
MODIFIED PCDNA3 PLASMID
MOLAR EXCESS
ANTIANDROGEN CYPROTERONE ACETATE MOLAR EXCESS
MOLECULAR WEIGHT SPECIES
MORPHOLOGICAL FEATURE
MORPHOLOGICAL GLAND INTEGRITY
MUTANT
MUTANT
MUTANT SKP2-ΔF
MUTANT P27
NEGATIVE CONTROL
NONFAT
NONFAT
NORMAL ANDROGEN CONTROL
NORMAL BIPHASIC MECHANISM
ANDROGEN CONTROL NORMAL BIPHASIC MECHANISM
NUCLEUS
OBSERVATION
OVEREXPRESSED
OVEREXPRESSED
OVEREXPRESSION
OVEREXPRESSION
OVEREXPRESSION
OVEREXPRESSION
OVEREXPRESSION
OVEREXPRESSION
OVEREXPRESSION
OVEREXPRESSION
OVEREXPRESSION
F-BOX OVEREXPRESSION
PTEN OVEREXPRESSION
SKP-ΔF OVEREXPRESSION
SKP2 OVEREXPRESSION
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27
P27 RNA LEVEL
P27 ABUNDANCE
P27 ACCUMULATION
P27 ACCUMULATION RESULT
P27 DEGRADATION
P27 DEGRADATION
P27 DEGRADATION
P27 DEPLETION
P27 DEPLETION
P27 DOWNREGULATION
P27 DOWNREGULATION
P27 EXPORT
P27 EXPRESSION
P27 EXPRESSION
P27 EXPRESSION
P27 GENE
P27 HALF-LIFE
P27 HALF-LIFE
P27 HALF-LIFE
P27 INACTIVATION
P27 LEVEL
P27 LEVEL
P27 LEVEL
P27 LEVEL
P27 LEVEL
P27 MRNA
P27 MRNA
P27 MRNA LEVEL
P27 PHOSPHORYLATION
P27 PHOSPHORYLATION
P27 PROTEIN
P27 PROTEIN
P27 PROTEIN LEVEL
P27 PROTEOLYSI
P27 REGULATION
P27 REGULATION
P27 STABILIZATION
P27 UBIQUITYLATION
P27 UBIQUITYLATION
P27 UBIQUITYLATION
P27 UBIQUITYLATION
P27 UBIQUITYLATION
P27 UBIQUITYLATION
P27 UBIQUITYLATION ACTIVITY
P27 UPREGULATION
P27 UPREGULATION
P27 UPREGULATION
P27 UPREGULATION
P27 UPREGULATION
PADTRACK1 SHUTTLE VECTOR
PH
PH
PARA-FORMALDEHYDE
PARALLEL EXPERIMENT
PATHWAY LEADING
PCDNA3
PELVIC LYMPH NODE METASTAS
PERFORMED IMMUNOFLUORESCENCE
PHOSPHOIMAGER
SIGNAL QUANTITATION PHOSPHOIMAGER
PHOSPHORYLATION
P27 PHOSPHORYLATION
POINT MUTANT
P27 POINT MUTANT
POLY-LYSINE
COATED GLASS COVERSLIP POLY-LYSINE
POTENTIAL TARGET
POTENTIAL TARGET
INTERVENTION POTENTIAL TARGET
THERAPEUTIC INTERVENTION POTENTIAL TARGET
POTENTIAL TRANSCRIPTION FACTOR
PRE-CASTRATION CELL NUMBER
PREVENTED P27 ACCUMULATION
PRIMARY CANCER SPECIMEN
PRIMARY RAT HEPATOCYTE
PROLIFERATING CELL
PROLIFERATION
PROLIFERATION
PROLIFERATION
PROLIFERATION
PROMOTING S PHASE ENTRY
MIB-ARRESTED LNCAP CELL PROMOTING S PHASE ENTRY
PROMOTING POSTMITOTIC DIFFERENTIATION
PROSTATE
PROSTATE CANCER
PROSTATE CANCER
PROSTATE CANCER CELL
PROSTATE CANCER
PROSTATE EPITHELIAL CELL PROLIFERATION
PROSTATE TUMOR SUPPRESSOR
PROSTATIC INTRAEPITHELIAL NEOPLASIA
PROTEASOME
PROTEIN
PROTEIN
PROTEIN
PROTEIN LEVEL
PROTEIN STABILITY
PROTEOLYTIC DOWNREGULATION
P27 PROTEOLYTIC DOWNREGULATION
PROXIMAL ELEMENT
RABBIT RETICULOCYTE LYSATE
RA
RAT FIBROBLAST
RAT FIBROBLAST
RAT FIBROBLAST
REACTION PRODUCT
RECOMBINATION
REDUCED P27 UBIQUITYLATION
REGENERATING SYSTEM
RESTING CELL
RESULTING PLASMID
REVERSE ANDROGEN-MEDIATED P27 ACCUMULATION
SAMPLE BUFFER
SAMPLE BUFFER
SAMPLE BUFFER
SECONDARY ANTIBODY
SERUM
STARVED RAT FIBROBLAST SERUM
SHOWED DOWN-REGULATION
P27 SHOWED DOWN-REGULATION
SIGNAL QUANTITATION
SIGNALOSOME
SIGNALOSOME SUBUNIT CSN5
SOLUTION
STABLE P27
STAINING PATTERN
STANDARD CALCIUM PHOSPHATE PROCEDURE
STARVED RAT FIBROBLAST
STATE RNA LEVEL
STEADY-STATE P27 PROTEIN LEVEL
STIMULATING CDK2 ACTIVITY
STIMULATING CELL
SUBJECT
SUBUNIT
COP9 SUBUNIT
SUPERNATANT
SYNERGIZE
SYNTHETIC ANDROGEN
SYNTHETIC ANDROGEN MIBOLERONE
SYSTEM EMPLOY
TARGET PROTEIN
THERAPEUTIC INTERVENTION
THREONINE
TIME POINT
TIME-DEPENDENT ACCUMULATION
TIME-DEPENDENT DOWNREGULATION
P27 TIME-DEPENDENT DOWNREGULATION
TIME-DEPENDENT INCREASE
TISSUE-SPECIFIC REGULATION
TRANSCRIPTIONAL TARGET
ANDROGEN RECEPTOR TRANSCRIPTIONAL TARGET
TRANSFECTED
TRANSFORMATION
TRANSFORMED PHENOTYPE
LNCAP CELL TRANSFORMED PHENOTYPE
TRANSIENT CHARACTER
TRANSIENT EPITHELIAL CELL PROLIFERATION
TRIS-BUFFERED SALINE
TUBULIN
TUBULIN LEVEL
TUMOR SUPPRESSOR
TURN BIND
TWO-FOLD
UBIQUITIN
UBIQUITIN
UBIQUITIN
UBIQUITIN
UBIQUITIN
UBIQUITIN CHAIN
CONJUGATING ENZYME UBIQUITIN
UBIQUITIN TRANSFER REACTION
UBIQUITIN-CONJUGATING ENZYME CDC34
UBIQUITIN/PROTEASOME SYSTEM
UBIQUITYLATION
UBIQUITYLATION ASSAY
UG
UG
UNKNOWN
UNKNOWN
UNRESPONSIVE
UPREGULATION
P27 UPREGULATION
UREA/LICL PROTOCOL
VIRAL ONCOPROTEIN
VITROUBIQUITYLATION ASSAY CELL LYSATE
UBIQUITYLATION ASSAY VITROUBIQUITYLATION ASSAY CELL LYSATE
WILDTYPE
WILDTYPE
ΜM MG132
ΜM OKADAIC ACID
ΜM UBIQUITIN ALDEHYDE
ΜG CELL LYSATE
ΜG/ML APROTININ
ΜG/ML APROTININ
ΜG/ML CREATINE KINASE
ΜG/ML LEUPEPTIN
ΜG/ML LEUPEPTIN
ΜG/ML PEPSTATIN
ΜG/ML PEPSTATIN
CDK
UBIQUITIN CONJUGATING
UBC
DIHYDROTESTOSTERONE
DHT
CYPROTERONE ACETATE
CA
AR
COP9/SIGNALOSOME
CSN
MANNER
AS3 OVEREXPRESSION
OVEREXPRESSION
activation
DNA
PHOTOSHOP
HYBOND N
ANDROGEN
controls
ANDROGEN-INDUCED
G1 ARREST
G1
VOGELSTEIN
C-TERMINAL LEUCINE-RICH
LEUCINE-RICH
SONNENSCHEIN
activation
activation
activation
inhibition
INHIBITOR P27
kinase
kinase
kinase
LYSATE
COMPLEMENTARY DNA
DNA
PROTEIN COMPLEX UBC
COMPLEX UBC
DHT-TREATED
ubiquitin ligases
UBIQUITIN
F-BOX
dependencies
P27 UBIQUITYLATION
P27
ARREST
ARREST
ARREST
probes
MS-JAB11-PX1
PS
IMMUNOLOGICAL
LNCAP
CELL LYSATE
LNCAP
CELL LYSATE
LNCAP
CELL LYSATE
LNCAP
CELL PROLIFERATION
LNCAP
LNCAP
LNCAP
LNCAP
LNCAP
LNCAP
LNCAP
LNCAP
LNCAP
LNCAP
LNCAP
LNCAP
LNCAP
LNCAP
LNCAP
LNCAP
LNCAP
CELLS EXHIBIT
LNCAP
MIB-ARRESTED LNCAP
MIB-ARRESTED
LNCAP
MIB-ARRESTED
MIB-ARRESTED
MIB-EXPOSED
MIB-INDUCED
G1 CELL CYCLE ARREST
CELL CYCLE ARREST
G1
MIB-INDUCED
G1 CELL CYCLE ARREST
CELL CYCLE ARREST
G1
MIB-INDUCED
RB1 DOWNREGULATION
RB1
MIB-INDUCED
CELL CYCLE ARREST
CYCLE ARREST
MIB-INDUCED
P27 UPREGULATION
P27
MIB-INDUCED
P27 UPREGULATION
P27
MIB-TREATED LNCAP
MIB-TREATED
LNCAP
MIB-TREATED
MIB-TREATED
MYC EPITOPE TAG
epitope tags
epitopes
BLOTTING ISOLATION
PERKIN ELMER LIFE
synthesis
PHOSPHORYLATION
SUPPRESSION
ADENOVIRAL DNA
PHASE ENTRY
PHASE ENTRY
PHASE ENTRY
PHASE KINASE
UPREGULATION
SKP2-MEDIATED P27
P27 DEGRADATION
P27
SKP2-MEDIATED P27
P27 DOWNREGULATION
P27
MUTANT
SKP2-ΔF OVEREXPRESSING
OVEREXPRESSING
administration
TRANSDUCTION
X100
X100
X100
X100
UBIQUITYLATION
films
RABBIT POLYCLONAL
PROSTATE CANCERS DISPLAY
CANCERS DISPLAY
ANDROGEN
ANDROGEN
administration
ANDROGEN
controls
ANDROGEN
controls
ANDROGEN
DIHYDROTESTOSTERONE
ANDROGEN
ANDROGEN
receptors
ANDROGEN
ANDROGEN-INDUCED
G1 ARREST
G1
ANDROGEN-INDUCED
growth arrest
ANDROGEN-INDUCED
P27 UPREGULATION
P27
ANDROGEN-MEDIATED
G1 ARREST
G1
ANDROGEN-MEDIATED
CELL CYCLE ARREST
CYCLE ARREST
ANDROGEN-MEDIATED
CELL CYCLE CONTROL
CYCLE CONTROL
ANDROGEN-MEDIATED
CELL CYCLE CONTROL
CYCLE CONTROL
ANDROGEN-MEDIATED
GROWTH CONTROL
ANDROGEN-MEDIATED P27
ANDROGEN-MEDIATED
P27 ACCUMULATION
P27
ANDROGEN-MEDIATED P27
ANDROGEN-MEDIATED
P27 CONTROL
P27
androgen-sensitive
HUMAN PROSTATE CANCER CELL LINE LNCAP
PROSTATE CANCER CELL LINE LNCAP
CANCER CELL LINE LNCAP
ANEUPLOID
AS3
ARRESTED LNCAP
LNCAP
ASYNCHRONOUS LNCAP
LNCAP
CASTRATION
ARREST
TRANSIENT UPREGULATION
CYCLE EXIT
cell lines
LINE LNCAP
cell lines
LYSATE
RNA
CHLORIDE GRADIENT CENTRIFUGATION
GRADIENT CENTRIFUGATION
BIPHASIC RESPONSE
BIPHASIC
EVIDENCE
ENZYME MIB
effects
PRESENCE
PRESENCE
controls
controls
controls
CDK2
PHOSPHORYLATION
CYCLIN
ES
CYCLIN
ES
CYCLIN
ES
CYCLIN
ES
CYCLIN
ES
CYCLIN
ES
CYCLIN E
CYCLIN
ES
CYCLIN E
CYCLIN
ES
CYCLIN E
CYCLIN
ES
CYCLIN E
CYCLIN
ES
kinase
CYCLIN E
CYCLIN
ES
CYCLIN E
CYCLIN
ES
CYCLIN
kinase
kinase
kinase
P27
SURVIVAL
UBIQUITYLATION
UBIQUITYLATION NORTHERN BLOT ANALYSIS
NORTHERN BLOT ANALYSIS
UBIQUITYLATION
DEMONSTRATED SKP2-INDEPENDENT
SKP2-INDEPENDENT
DIFFERENTIATED SECRETORY
SECRETORY
displays
DOWNREGULATE P27
downregulates
P27
S PHASE ENTRY
PHASE ENTRY
SS
ECTOPIC
degradation
ECTOPIC
ESCAPE
enzymatic
EXOGENOUS AR
cytometry
cytometry
P27
GROWTH
inhibition
H
COURSE
homozygous
INACTIVATION
E1
HUMAN U87
U87
HUMAN U87
U87
HUMAN U87
U87
lamins
B
HYPOTONIC
LYSIS
HYPOTONIC
LYSIS
ANDROGEN-MEDIATED PATHWAY
ANDROGEN-MEDIATED
INCREASED P27
P27
INCREASED P27
P27
UBIQUITYLATION
RECOVERY
RECOVERY
inhibition
inhibitors
P27
carcinomas
correlations
ANDROGEN ADMINISTRATION
ANDROGEN
LACKING CSN
CSN
ATP
ATP
DTT
KCL
NACL
PMSF
PMSF
TRIS
CREATINE
DETERMINANT
lesions
mg/ml
UBIQUITIN
PCDNA3 PLASMID
PCDNA3
EXCESS
molecular weight
MUTANT
MUTANT
P27
controls
ANDROGEN CONTROL
ANDROGEN
BIPHASIC
P27 RNA
P27
RNA
P27
P27
ACCUMULATION
P27 ACCUMULATION
P27
P27
degradation
P27
degradation
P27
degradation
P27
DEPLETION
P27
DEPLETION
P27
DOWNREGULATION
P27
DOWNREGULATION
P27
EXPORT
P27
expressions
P27
expressions
P27
expressions
P27
genes
P27
P27
P27
P27
INACTIVATION
P27
P27
P27
P27
P27
P27
MRNA
P27
MRNA
P27 MRNA
P27
MRNA
P27
PHOSPHORYLATION
P27
PHOSPHORYLATION
P27
P27
P27
P27
P27
REGULATION
P27
REGULATION
P27
stabilization
P27
UBIQUITYLATION
P27
UBIQUITYLATION
P27
UBIQUITYLATION
P27
UBIQUITYLATION
P27
UBIQUITYLATION
P27
UBIQUITYLATION
P27 UBIQUITYLATION
P27
UBIQUITYLATION
P27
UPREGULATION
P27
UPREGULATION
P27
UPREGULATION
P27
UPREGULATION
P27
UPREGULATION
parallel
experiments
pathways
IMMUNOFLUORESCENCE
MUTANT
targets
targets
transcription factors
P27 ACCUMULATION
P27
PRIMARY
PRIMARY
S PHASE ENTRY
PHASE ENTRY
SS
postmitotic differentiation
epithelial cell proliferation
CELL PROLIFERATION
epithelial
TUMOR SUPPRESSOR
INTRAEPITHELIAL NEOPLASIA
proteolytic
DOWNREGULATION
proximal
RETICULOCYTE LYSATE
reactions
P27 UBIQUITYLATION
P27
plasmid
ANDROGEN-MEDIATED P27 ACCUMULATION
P27 ACCUMULATION
ANDROGEN-MEDIATED
P27
BUFFER
BUFFER
BUFFER
signals
quantitation
SIGNALOSOME
SUBUNIT CSN5
SUBUNIT
P27
standards
STATE RNA
RNA
P27
CDK2
ANDROGEN
SYNTHETIC ANDROGEN
ANDROGEN MIBOLERONE
ANDROGEN
targets
INTERVENTION
times
ACCUMULATION
DOWNREGULATION
increases
REGULATION
transcriptional
targets
phenotype
epithelial cell proliferation
CELL PROLIFERATION
epithelial
TUBULIN
TURN
UBIQUITIN
UBIQUITIN
TRANSFER REACTION
ENZYME CDC34
UBIQUITYLATION
protocols
ΜM
MG132
ΜM
ΜM
UBIQUITIN ALDEHYDE
UBIQUITIN
μg
CELL LYSATE
μg/ml
aprotinin
μg/ml
aprotinin
μg/ml
CREATINE KINASE
CREATINE
μg/ml
leupeptin
μg/ml
leupeptin
μg/ml
pepstatin
μg/ml
pepstatin
